Parexel supports the development of innovative new medicines to improve the health of patients. We provide services to help life sciences and biopharmaceutical clients everywhere transform scientific discoveries into new treatments. From decentralized clinical trials to regulatory consulting services to leveraging real world insights, our therapeutic, technical, and functional ability is underpinned by a deep conviction in what we do. Parexel was named “Best Contract Research Organization” in December 2020 by an independent panel for Informa Pharma Intelligence.

C-Suite On Deck

Responsive image

Q&A with Cecil Nick, Vice President at Parexel

Media 7 | August 2, 2021

Cecil Nick, Vice President (Biotechnology) at Parexel, is a biochemistry graduate and regulatory professional with over 30 years experience specializing in the clinical development of biological and biotech products. He has supported 7 biosimilar marketing approvals and has over 80 biosimilar Agency interactions in EU, US, Canada and RoW. He offers extensive expertise to clients with respect to biosimilars, comparabilty, clinical development, orphan drugs and training. He is a fellow of TOPRA and has been a guest lecture at Cardiff University for MSc in Clinical Research, and Greenwich University for MSc in Pharmaceutical Sciences, courses and Biotech Module leader for the TOPRA MSc course. He was on the editorial panel of SCRIP Clinical Research and has over 30 publications to his name.

Read More

Events

Related News

HEALTH VECTOR IS PIONEERING INNOVATIVE AI APPROACHES TO SUPPORT MEDICAL DOCUMENTATION

Health Vector | July 13, 2020

news image

Health Vector recently partnered with a major healthcare system to garner the power of AI to support medical documentation. The new product, Health Vector Clinical Transcriptions, demonstrates how instant transcription of medical encounters helps clinicians save time, improve accuracy, and enhance interactions with patients.The functionality in Health Vector Clinical Transcriptions is built around real-time transcription of conversations which are scrubbed of personally identifiable inform...

Read More

ANTHEM LARGELY WITHDRAWS 2020 GUIDANCE DUE TO COVID-19 UNCERTAINTY

Anthem | April 29, 2020

news image

Anthem earned $1.5 billion in profit for the first quarter of 2019, missing Wall Street's expectations. The insurer raked in $29.6 billion in revenue for the quarter, it said in its earnings release Wednesday. That was up about 20% from $24.7 billion in the first quarter of 2019. In its earnings report (PDF), Anthem touted the steps it has taken to date to combat the COVID-19 pandemic, which include easing administrative burdens on providers, waiving cost-sharing for testing an...

Read More

Healthcare Analytics

ANNEXUS HEALTH PARTNERS WITH OMEGA HEALTHCARE

PRNewswire | June 12, 2023

news image

Annexus Health, Inc., the leading healthcare technology company that is revolutionizing the patient access journey through its innovative solutions, today announced its partnership with healthcare management solutions provider Omega Healthcare. Ranked among the top revenue cycle management business service providers by industry analysts, Omega Healthcare leverages its AI and data analytics-based solutions and experienced staff in the U.S. and worldwide to streamline medical bill...

Read More

CORONAVIRUS DRIVES TELADOC’S DAILY VIRTUAL MEDICAL VISITS UP 50%

HIT Consultant | March 16, 2020

news image

Virtual care provider Teladoc Health announced that the company is experiencing unprecedented daily visit volume in the United States as the novel coronavirus (COVID-19) continues to spread globally. This week, patient visit volume spiked 50 percent over the prior week and continues to rise. The company had been handling visit demand consistent with peak flu volumes, but last week Wednesday began to see that number accelerate to as much as 15,000 visits requested per day. Teladoc Health has prov...

Read More
news image

HEALTH VECTOR IS PIONEERING INNOVATIVE AI APPROACHES TO SUPPORT MEDICAL DOCUMENTATION

Health Vector | July 13, 2020

Health Vector recently partnered with a major healthcare system to garner the power of AI to support medical documentation. The new product, Health Vector Clinical Transcriptions, demonstrates how instant transcription of medical encounters helps clinicians save time, improve accuracy, and enhance interactions with patients.The functionality in Health Vector Clinical Transcriptions is built around real-time transcription of conversations which are scrubbed of personally identifiable inform...

Read More
news image

ANTHEM LARGELY WITHDRAWS 2020 GUIDANCE DUE TO COVID-19 UNCERTAINTY

Anthem | April 29, 2020

Anthem earned $1.5 billion in profit for the first quarter of 2019, missing Wall Street's expectations. The insurer raked in $29.6 billion in revenue for the quarter, it said in its earnings release Wednesday. That was up about 20% from $24.7 billion in the first quarter of 2019. In its earnings report (PDF), Anthem touted the steps it has taken to date to combat the COVID-19 pandemic, which include easing administrative burdens on providers, waiving cost-sharing for testing an...

Read More
news image

Healthcare Analytics

ANNEXUS HEALTH PARTNERS WITH OMEGA HEALTHCARE

PRNewswire | June 12, 2023

Annexus Health, Inc., the leading healthcare technology company that is revolutionizing the patient access journey through its innovative solutions, today announced its partnership with healthcare management solutions provider Omega Healthcare. Ranked among the top revenue cycle management business service providers by industry analysts, Omega Healthcare leverages its AI and data analytics-based solutions and experienced staff in the U.S. and worldwide to streamline medical bill...

Read More
news image

CORONAVIRUS DRIVES TELADOC’S DAILY VIRTUAL MEDICAL VISITS UP 50%

HIT Consultant | March 16, 2020

Virtual care provider Teladoc Health announced that the company is experiencing unprecedented daily visit volume in the United States as the novel coronavirus (COVID-19) continues to spread globally. This week, patient visit volume spiked 50 percent over the prior week and continues to rise. The company had been handling visit demand consistent with peak flu volumes, but last week Wednesday began to see that number accelerate to as much as 15,000 visits requested per day. Teladoc Health has prov...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Q&A with Cecil Nick, Vice President at Parexel

Media 7 | August 2, 2021

Cecil Nick, Vice President (Biotechnology) at Parexel, is a biochemistry graduate and regulatory professional with over 30 years experience specializing in the clinical development of biological and biotech products. He has supported 7 biosimilar marketing approvals and has over 80 biosimilar Agency interactions in EU, US, Canada and RoW. He offers extensive expertise to clients with respect to biosimilars, comparabilty, clinical development, orphan drugs and training. He is a fellow of TOPRA and has been a guest lecture at Cardiff University for MSc in Clinical Research, and Greenwich University for MSc in Pharmaceutical Sciences, courses and Biotech Module leader for the TOPRA MSc course. He was on the editorial panel of SCRIP Clinical Research and has over 30 publications to his name.

Read More